After the injections, the tumour sizes and weights were measured, and we observed that all the tumours in the PKCα‐overexpressing plasmid group increased in size and weight compared with those in the PKCα‐vector group (Figure 2A‐C). The gene discussed is PRKCA; the disease is neoplasm.